Endogenous inhibitors of monoamine oxidase present in human cerebrospinal fluid.
Inhibitory activity against the enzyme monoamine oxidase is present in low molecular weight fractions (less than 100,000) of human cerebrospinal fluid. These endogenous substances of different molecular weights (3000 to more than 35,000) act like monoamine oxidase inhibitor drugs to inhibit both type A and type B monoamine oxidase.
D000818:Animals; D002555:Cerebrospinal Fluid / Q000502:physiology*; D002850:Chromatography, Gel; D006801:Humans; D008970:Molecular Weight; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000302:isolation & purification*; D051381:Rats
D008996:Monoamine Oxidase Inhibitors; D008995:Monoamine Oxidase